Gossamer Bio GOSS
NASDAQ GOSS
$10.71 -0.22 (-2.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

Gossamer Bio (GOSS) posted Return on Capital Employed [ROCE] of -190.06% for Q1 2026, down 168.13 percentage points from -21.93% a year earlier and down 55.73 percentage points from the prior quarter.

Analysis

Gossamer Bio (GOSS) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025, Gossamer Bio's Return on Capital Employed [ROCE] came in at -94.67%, down 72.36 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -42.02 percentage points (FY2020 to FY2025).
  • In prior years, Gossamer Bio's Return on Capital Employed [ROCE] was -22.31% in FY2024 (+54.07 pp), -76.38% in FY2023 (+8.08 pp), -84.46% in FY2022 (-30.65 pp) and -53.80% in FY2021 (-1.15 pp).
  • The Q1 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2019.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last four quarters, with an average year-over-year change of -18.00 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q2 2024, with a gain of 98.07 percentage points; the weakest was Q1 2026, with a drop of 168.13 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -134.33% (Q4 2025), -98.81% (Q3 2025) and -70.29% (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Gossamer Bio 42.84 Mn -430.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -190.06%
Dec 31, 2025 -134.33%
Sep 30, 2025 -98.81%
Jun 30, 2025 -70.29%
Mar 31, 2025 -21.93%
Dec 31, 2024 -20.80%
Sep 30, 2024 -23.41%
Jun 30, 2024 -29.27%
Mar 31, 2024 -71.16%
Dec 31, 2023 -66.02%
Sep 30, 2023 -84.98%
Jun 30, 2023 -127.34%
Mar 31, 2023 -103.20%
Dec 31, 2022 -87.87%
Sep 30, 2022 -93.04%
Jun 30, 2022 -95.43%
Mar 31, 2022 -76.34%
Dec 31, 2021 -66.40%
Sep 30, 2021 -60.06%
Jun 30, 2021 -52.04%
API Access

Gossamer Bio Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GOSS&period=max&api_key=YOUR_API_KEY